GlassScriptPhysician profile
Jennifer Moore
NPI 1962086165
$3,587.07
in general payments reported to CMS, 2019-2025
12 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.72 · 2022: $2,939 · 2024: $218 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,965.26 | 2021-2022 | |
| Corcept Therapeutics | $134.50 | 2024-2025 | Korlym |
| Idorsia Pharmaceuticals US INC | $98.55 | 2024 | Quviviq |
| Tactile Systems Technology INC | $76.60 | 2025 | Flexitouch Plus, Nimbl |
| Astrazeneca Pharmaceuticals LP | $73.60 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $64.40 | 2025 | |
| Axsome Therapeutics, INC. | $54.72 | 2025 | Auvelity |
| Jazz Pharmaceuticals INC. | $46.28 | 2024-2025 | |
| Dexcom, INC. | $22.15 | 2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $20.06 | 2025 | Varithena Administration Pack |
| Pfizer INC. | $16.54 | 2025 | |
| Acella Pharmaceuticals, LLC | $14.41 | 2025 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.